Plasma Chromogranin B as a Marker of Tumor Burden and Radiological Progression in Neuroendocrine Tumors

被引：0
|
作者：
Braude, D. [1 ]
Bartholomew, T. K. [1 ]
Rossi, R. E. [1 ]
Garcia-Hernandez, A. [1 ]
Mullan, M. [1 ]
Caplin, M. [1 ]
Toumpanakis, C. [1 ]
机构：
[1] Royal Free Hosp, ENETS Ctr Excellence, Neuroendocrine Tumour Unit, London NW3 2QG, England
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
chromogranin b; midgut nets; pancreatic net; progression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H3
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [41] Chromogranin A as a Predictor of Progression, Regression or Stable Disease in Ileo-Cecal Neuroendocrine Tumors
    Jensen, K.
    Hilsted, L.
    Jensen, C.
    Mynster, T.
    Knigge, U.
    NEUROENDOCRINOLOGY, 2011, 94 : 6 - 6
  • [42] CHROMOGRANIN-A - ITS ROLE IN ENDOCRINE FUNCTION AND AS AN ENDOCRINE AND NEUROENDOCRINE TUMOR-MARKER
    DEFTOS, LJ
    ENDOCRINE REVIEWS, 1991, 12 (02) : 181 - 187
  • [43] Relevance of Serum Chromogranin A as Diagnostic and Prognostic Marker for Well-Differentiated Pancreatic Neuroendocrine Tumors
    Pulvirenti, Alessandra
    Rao, Deepthi
    Tang, Laura
    Gonen, Mithat
    Fleisher, Martin
    Reidy-Lagunes, Diane
    Allen, Peter
    PANCREAS, 2018, 47 (03) : 352 - 353
  • [44] IMMUNOHISTOCHEMICAL DISTRIBUTION OF CHROMOGRANIN-A AND CHROMOGRANIN-B AND SECRETOGRANIN-II IN NEUROENDOCRINE TUMORS OF THE GASTROINTESTINAL-TRACT
    FAHRENKAMP, AG
    WIBBEKE, C
    WINDE, G
    OFNER, D
    BOCKER, W
    FISCHERCOLBRIE, R
    SCHMID, KW
    VIRCHOWS ARCHIV, 1995, 426 (04) : 361 - 367
  • [45] Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population
    Hong, Liwen
    Wang, Yuan
    Zhang, Tianyu
    Zhang, Chen
    Wang, Lei
    Wang, Liying
    Wang, Zhengting
    Zhong, Jie
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [46] Clinical Usefulness of Plasma Chromogranin a Level in the Patients With a Locally Treatable Rectal Neuroendocrine Tumor
    Yang, Dong-Hoon
    Hwang, Sung Wook
    Park, Sang Hyoung
    Ye, Byong Duk
    Myung, Seung-Jae
    Park, Yangsoon
    Yang, Suk-Kyun
    Byeon, Jeong-Sik
    GASTROENTEROLOGY, 2016, 150 (04) : S302 - S302
  • [47] A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors
    Dam, G.
    Gronbaek, H.
    Sorbye, H.
    Thiis-Evensen, E.
    Paulsson, B.
    Sundin, A.
    Jensen, C.
    Ebbesen, D.
    Knigge, U.
    Janson, Tiensuu E.
    NEUROENDOCRINOLOGY, 2018, 106 : 152 - 152
  • [48] The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors
    Kim, Moonjin
    Lee, Sujin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Kang, Won Ki
    Kim, Seung Tae
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 153 - 161
  • [49] Gamma-glutamyltransferase as an indicator of hepatic tumor burden in neuroendocrine tumors
    Schmidt, B.
    Leiderer, M.
    Amin, T.
    Viol, F.
    Adam, G.
    Huber, S.
    Henes, F. O.
    Schrader, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 118 - 118
  • [50] A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients With Pancreatic and Small Intestinal Neuroendocrine Tumors
    Dam, Gitte
    Groenbaek, Henning
    Soerbye, Halfdan
    Evensen, Espen Thiis
    Paulsson, Bjorn
    Sundin, Anders
    Jensen, Claus
    Ebbesen, Dyveke
    Knigge, Ulrich
    Janson, Eva Tiensuu
    PANCREAS, 2019, 48 (03) : 432 - 432
12345